Summit Therapeutics PLC | Cash Flow
Fiscal year is February-January. All values GBP Thousands.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
6,700.00
12,660.00
23,195.00
25,707.00
10,893.00
5,031
Depreciation, Depletion & Amortization
26.00
33.00
48.00
58.00
246.00
1,138
Other Funds
-
-
-
23.00
-
6,063
Funds from Operations
6,260.00
10,941.00
17,892.00
19,683.00
6,577.00
12,232
Changes in Working Capital
400.00
333.00
740.00
31,832.00
8,100.00
39,023
Net Operating Cash Flow
5,860.00
11,274.00
17,152.00
12,149.00
14,677.00
26,791
Capital Expenditures
47.00
35.00
66.00
88.00
479.00
Sale of Fixed Assets & Businesses
102.00
-
-
-
-
Net Investing Cash Flow
55.00
35.00
66.00
88.00
5,254.00
Net Financing Cash Flow
4,456.00
20,544.00
22,136.00
413.00
13,905.00
Net Change in Cash
1,349.00
9,235.00
5,039.00
11,758.00
7,960.00
Free Cash Flow
5,897.00
11,309.00
17,218.00
12,068.00
15,037.00
Net Assets from Acquisitions
-
-
-
-
4,775.00
Change in Capital Stock
4,456.00
20,544.00
22,136.00
390.00
13,905.00
Exchange Rate Effect
-
-
121.00
716.00
1,934.00
About Summit Therapeutics
View Profile
